NIH Innovation, CURES Act
Schedules
TAFS: 075-5628 /X - NIH Innovation, CURES Act
| Line # | Split | Description | Iteration 1 Previously Approved Amount | Iteration 2 Current OMB Action Amount | Footnotes |
|---|---|---|---|---|---|
| 1000 | DE | Discretionary Expected - Unob Bal: Brought forward, October 1 | $9,144,155 | -$9,144,155 $0 | |
| 1000 | DA | Discretionary Actual - Unob Bal: Brought forward, October 1 | Line added— | +$7,299,455 $7,299,455 | See footnotes below |
| Footnotes for line 1000 (DA) (Current): | B1: Pursuant to P.L. 119-4 and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001, NIH CURES Act innovation projects funds remain available until expended. | ||||
| 1033 | Unob Bal: Recov of prior year paid obligations | Line added— | +$285,892 $285,892 | ||
| 1047 | Unob Bal: Withdrawal for existing unpaid obls | Line added— | -$284,756 -$284,756 | ||
| 1061 | Unob Bal: Antic recov of prior year unpd/pd obl | $10,000,000 | +$5,000,000 $15,000,000 | ||
| 1101 | BA: Disc: Appropriation (special or trust) | Line added— | +$226,000,000 $226,000,000 | See footnotes below | |
| Footnotes for line 1101 (Current): | B2: Pursuant to P.L. 114-255, section 1001, NIH CURES Act innovation projects are funded in the amount of $226,000,000 to remain available until expended. | ||||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | Line added— | -$195,000,000 -$195,000,000 | See footnotes below | |
| Footnotes for line 1151 (Current): | B3: Pursuant to P.L. 119-75, and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001. | ||||
| 1920 | Total budgetary resources avail (disc. and mand.) | $19,144,155 | +$34,156,436 $53,300,591 | See footnotes below | |
| Footnotes for line 1920 (Current): | B4: Pursuant to section 120.21 of OMB Circular A-11, one or more lines in the Budgetary Resources section may be rounded up. As a result, those rounded lines will not match the actuals reported on the SF 133. Agency will ensure that its funds control system will only allot actuals. | ||||
| 6011 | NIH Innovation, CURES Act | $19,144,155 | +$34,156,436 $53,300,591 | ||
| 6190 | Total budgetary resources available | $19,144,155 | +$34,156,436 $53,300,591 | See footnotes below | |
| Footnotes for line 6190 (Previous): | A1: The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available without further action by OMB. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | ||||
| Footnotes for line 6190 (Current): | A1: The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available without further action by OMB. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | ||||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| A1 | The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available without further action by OMB. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] |
| B1 | Pursuant to P.L. 119-4 and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001, NIH CURES Act innovation projects funds remain available until expended. |
| B2 | Pursuant to P.L. 114-255, section 1001, NIH CURES Act innovation projects are funded in the amount of $226,000,000 to remain available until expended. |
| B3 | Pursuant to P.L. 119-75, and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001. |
| B4 | Pursuant to section 120.21 of OMB Circular A-11, one or more lines in the Budgetary Resources section may be rounded up. As a result, those rounded lines will not match the actuals reported on the SF 133. Agency will ensure that its funds control system will only allot actuals. |
The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.
| Number | Text |
|---|---|
| A1 | The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available without further action by OMB. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.